Mutations in gyrA and gyrB among drug-resistant Mycobacterium tuberculosis isolates in South Korea
{{output}}
Background: Group A fluoroquinolones (FLQs) are essential for treating multidrug-resistant tuberculosis (MDR-TB). Mutations in gyrA and gyrB cause FLQ resistance, but their patterns vary by region. This study evaluated FLQ-associ... ...
